629 related articles for article (PubMed ID: 21486121)
21. Direct targeting of β-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling.
Hahne G; Grossmann TN
Bioorg Med Chem; 2013 Jul; 21(14):4020-6. PubMed ID: 23566764
[TBL] [Abstract][Full Text] [Related]
22. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.
Fevr T; Robine S; Louvard D; Huelsken J
Mol Cell Biol; 2007 Nov; 27(21):7551-9. PubMed ID: 17785439
[TBL] [Abstract][Full Text] [Related]
23. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
25. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
[TBL] [Abstract][Full Text] [Related]
26. High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway.
Liu N; Shi S; Deng M; Tang L; Zhang G; Liu N; Ding B; Liu W; Liu Y; Shi H; Liu L; Jin Y
J Bone Miner Res; 2011 Sep; 26(9):2082-95. PubMed ID: 21638320
[TBL] [Abstract][Full Text] [Related]
27. Targeting Wnt signaling in colon cancer stem cells.
de Sousa EM; Vermeulen L; Richel D; Medema JP
Clin Cancer Res; 2011 Feb; 17(4):647-53. PubMed ID: 21159886
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
[TBL] [Abstract][Full Text] [Related]
29. Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
Lee MA; Kim WK; Park HJ; Kang SS; Lee SK
Bioorg Med Chem Lett; 2013 Oct; 23(20):5511-4. PubMed ID: 24018191
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Wnt/β-catenin signaling by p38 MAP kinase inhibitors is explained by cross-reactivity with casein kinase Iδ/ɛ.
Verkaar F; van der Doelen AA; Smits JF; Blankesteijn WM; Zaman GJ
Chem Biol; 2011 Apr; 18(4):485-94. PubMed ID: 21513885
[TBL] [Abstract][Full Text] [Related]
31. Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis.
Naito AT; Shiojima I; Akazawa H; Hidaka K; Morisaki T; Kikuchi A; Komuro I
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19812-7. PubMed ID: 17170140
[TBL] [Abstract][Full Text] [Related]
32. Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells.
Li HX; Luo X; Liu RX; Yang YJ; Yang GS
Mol Cell Endocrinol; 2008 Sep; 291(1-2):116-24. PubMed ID: 18584948
[TBL] [Abstract][Full Text] [Related]
33. The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans.
Marchand A; Atassi F; Gaaya A; Leprince P; Le Feuvre C; Soubrier F; Lompré AM; Nadaud S
Aging Cell; 2011 Apr; 10(2):220-32. PubMed ID: 21108734
[TBL] [Abstract][Full Text] [Related]
34. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.
Ying Y; Tao Q
Epigenetics; 2009 Jul; 4(5):307-12. PubMed ID: 19633433
[TBL] [Abstract][Full Text] [Related]
36. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
37. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.
Cavard C; Colnot S; Audard V; Benhamouche S; Finzi L; Torre C; Grimber G; Godard C; Terris B; Perret C
Future Oncol; 2008 Oct; 4(5):647-60. PubMed ID: 18922122
[TBL] [Abstract][Full Text] [Related]
38. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.
García-Jiménez C; García-Martínez JM; Chocarro-Calvo A; De la Vieja A
J Mol Endocrinol; 2014 Feb; 52(1):R51-66. PubMed ID: 24049067
[TBL] [Abstract][Full Text] [Related]
39. The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac.
Tai WP; Hu PJ; Wu J; Lin XC
Tumori; 2014; 100(1):97-101. PubMed ID: 24675499
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.
Vallée A; Lecarpentier Y; Vallée JN
Cells; 2019 Jul; 8(7):. PubMed ID: 31311204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
